Higher-Order Structure Comparability: Case Studies of BioSimilar Monoclonal Antibodies
Reporter: Larry H. Bernstein, MD, FCAP
DR ANTHONY MELVIN CRASTO, Worlddrugtracker
MAbs and antibody–drug conjugates (ADCs) are among the fastest growing biologic segments in development, with hundreds of candidates currently under clinical study.
read at
http://www.bioprocessintl.com/manufacturing/biosimilars/higher-order-structure-comparability/
2012pharmaceutical
sjwilliamspa
Leave a Reply